drugset / Trial / NCT05658107
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 765423 in healthy male subjects following intravenous administration of single rising doses.
Timeline
- Start
- 2023-01-16
- Primary completion
- 2024-03-19
- Completion
- 2024-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 765423 | Unknown | — | Intravenous |
Indications
No indication recorded.